Valeritas Holdings, Inc. (NASDAQ:VLRX) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued to investors on Wednesday, July 19th.
VLRX has been the subject of several other research reports. Cowen and Company initiated coverage on Valeritas Holdings in a report on Monday, April 17th. They issued an “outperform” rating for the company. Wedbush initiated coverage on Valeritas Holdings in a report on Monday, July 10th. They issued an “outperform” rating and a $12.00 price objective for the company. Finally, B. Riley restated a “buy” rating and issued a $10.00 price objective on shares of Valeritas Holdings in a report on Wednesday, May 17th.
Shares of Valeritas Holdings (VLRX) opened at 5.49 on Wednesday. The stock’s 50 day moving average price is $5.89 and its 200 day moving average price is $13.58. The stock’s market cap is $37.56 million. Valeritas Holdings has a 1-year low of $4.51 and a 1-year high of $50.00.
Valeritas Holdings (NASDAQ:VLRX) last released its earnings results on Friday, May 12th. The company reported ($6.92) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($2.72) by $4.20. The business had revenue of $4.61 million during the quarter, compared to analysts’ expectations of $4.64 million. On average, equities research analysts anticipate that Valeritas Holdings will post ($8.23) EPS for the current fiscal year.
In related news, insider John Edward Timberlake acquired 5,000 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was purchased at an average cost of $5.14 per share, for a total transaction of $25,700.00. Following the completion of the transaction, the insider now directly owns 23,037 shares of the company’s stock, valued at approximately $118,410.18. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have purchased 11,500 shares of company stock valued at $57,615 in the last quarter. 1.20% of the stock is currently owned by corporate insiders.
An institutional investor recently bought a new position in Valeritas Holdings stock. C WorldWide Group Holding A S purchased a new position in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned 3.42% of Valeritas Holdings at the end of the most recent quarter. 11.65% of the stock is currently owned by institutional investors and hedge funds.
Valeritas Holdings Company Profile
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
